![JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial](https://www.mdpi.com/jcm/jcm-11-05632/article_deploy/html/images/jcm-11-05632-g002-550.jpg)
JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
![Prophylaxis of cancer‑associated venous thromboembolism with low‑molecular‑weight heparin‑tinzaparin: Real world evidence Prophylaxis of cancer‑associated venous thromboembolism with low‑molecular‑weight heparin‑tinzaparin: Real world evidence](https://www.spandidos-publications.com/article_images/ol/23/4/ol-23-04-13235-g04.jpg)
Prophylaxis of cancer‑associated venous thromboembolism with low‑molecular‑weight heparin‑tinzaparin: Real world evidence
Tinzaparin sodium: a review of its use in the prevention and treatment of deep vein thrombosis and pulmonary embolism, and in the prevention of clotting in the extracorporeal circuit during Haemodialysis -
Article: No accumulation of a prophylactic dose of nadroparin in moderate renal insufficiency (full text) - October 2015 - NJM
![Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis - M. José Martínez-Zapata, Alexander G. Mathioudakis, Shaker A. Mousa, Rupert Bauersachs, 2018 Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis - M. José Martínez-Zapata, Alexander G. Mathioudakis, Shaker A. Mousa, Rupert Bauersachs, 2018](https://journals.sagepub.com/cms/10.1177/1076029617696581/asset/images/large/10.1177_1076029617696581-fig4.jpeg)
Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis - M. José Martínez-Zapata, Alexander G. Mathioudakis, Shaker A. Mousa, Rupert Bauersachs, 2018
![JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial](https://www.mdpi.com/jcm/jcm-11-05632/article_deploy/html/images/jcm-11-05632-g003.png)
JCM | Free Full-Text | Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial
![CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients | BMC Cancer | Full Text CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1471-2407-13-284/MediaObjects/12885_2012_Article_3925_Fig1_HTML.jpg)